Cargando…
Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
BACKGROUND AND OBJECTIVE: Emerging evidence has proven the robust role of tumor mutation burden (TMB) and immune cell infiltration (ICI) in cancer immunotherapy. However, the precise effect of TMB and ICI on clear cell renal cell carcinoma (ccRCC) remains elusive and merits further investigation. Th...
Autores principales: | Zhang, Haoxun, Liu, Yiwen, Wang, Bowen, Wang, Chunyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327257/ https://www.ncbi.nlm.nih.gov/pubmed/35883015 http://dx.doi.org/10.1186/s12863-022-01076-4 |
Ejemplares similares
-
Overexpression of interleukin-20 receptor subunit beta (IL20RB) correlates
with cell proliferation, invasion and migration enhancement and poor prognosis in
papillary renal cell carcinoma
por: Cui, Xi-Feng, et al.
Publicado: (2019) -
Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma
por: Guo, Hongda, et al.
Publicado: (2022) -
Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma
por: Zhang, Haoxun, et al.
Publicado: (2023) -
The IL-20RB receptor and the IL-20 signaling pathway in regulating host defense in oral mucosal candidiasis
por: Beute, John E., et al.
Publicado: (2022) -
IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer
por: He, Yunfei, et al.
Publicado: (2022)